These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 28326595)

  • 21. Urticaria and anaphylaxis to povidone in a paracetamol preparation.
    Bergendorff O; Hansson C
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):573-4. PubMed ID: 17374012
    [No Abstract]   [Full Text] [Related]  

  • 22. [Tablet preparation by direct pressing].
    Hüttenrauch R; Schmeiss U
    Pharmazie; 1968 Sep; 23(9):473-9. PubMed ID: 4304790
    [No Abstract]   [Full Text] [Related]  

  • 23. Influence of complex formation on drug release from tablets.
    Jürgensen Eide G
    Acta Pharm Suec; 1973 Jun; 10(3):229-46. PubMed ID: 4729700
    [No Abstract]   [Full Text] [Related]  

  • 24. A methadone user with anaemia, skeletal pain and altered appearance.
    Kaur P; Bergrem A; Gerlyng P; Reims HM; Leh S; Valeur J
    Tidsskr Nor Laegeforen; 2016 Jun; 136(10):925-9. PubMed ID: 27272371
    [No Abstract]   [Full Text] [Related]  

  • 25. Anaphylaxis to povidone in a child.
    Pedrosa C; Costa H; Oliveira G; Romariz J; Praça F
    Pediatr Allergy Immunol; 2005 Jun; 16(4):361-2. PubMed ID: 15943602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rheological studies on dispersions of polyvinylprrolidone. I. General flow characteristics.
    Kassem MA; Mattha AG
    Pharm Acta Helv; 1970 Jan; 45(1):18-27. PubMed ID: 5436731
    [No Abstract]   [Full Text] [Related]  

  • 27. The use of polyvinylpyrrolidone (PVP) in coprecipitation.
    Sultana N; Arayne SM; Saify ZS
    J Pak Med Assoc; 1979 Apr; 29(4):77-80. PubMed ID: 108427
    [No Abstract]   [Full Text] [Related]  

  • 28. Multidisciplinary approach on characterizing a mechanochemically activated composite of vinpocetine and crospovidone.
    Hasa D; Voinovich D; Perissutti B; Bonifacio A; Grassi M; Franceschinis E; Dall'Acqua S; Speh M; Plavec J; Invernizzi S
    J Pharm Sci; 2011 Mar; 100(3):915-32. PubMed ID: 20839363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of moisture sorption on the performance of crospovidone.
    Hiew TN; Johan NAB; Desai PM; Chua SM; Loh ZH; Heng PWS
    Int J Pharm; 2016 Nov; 514(1):322-331. PubMed ID: 27863679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Usage of polyvinylpyrrolidonic films for nasal cavity tamponade].
    Kriukov AI; Karel'skaia NA; Kleshnin DA; Pashkin II
    Vestn Otorinolaringol; 2006; (1):28-30. PubMed ID: 16482006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Minimally invasive treatment of female urinary incontinence due to sphincter incompetence].
    Franceschetti GP; Bagliani F; Marchetti S; Vicini D
    Chir Ital; 1998; 50(1):17-24. PubMed ID: 9732819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the physicochemical characteristics of crospovidone that influence solid dispersion preparation.
    Nakanishi S; Fujii M; Sugamura Y; Suzuki A; Shibata Y; Koizumi N; Watanabe Y
    Int J Pharm; 2011 Jul; 413(1-2):119-25. PubMed ID: 21549186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deactivation of mycotoxins. I. An in vitro study of zearalenone adsorption on new polymeric adsorbents.
    Alegakis AK; Tsatsakis AM; Shtilman MI; Lysovenko DL; Vlachonikolis IG
    J Environ Sci Health B; 1999 Jul; 34(4):633-44. PubMed ID: 10390851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the Gordon-Taylor and Couchman-Karasz equations for prediction of the glass transition temperature of glass solutions of drug and polyvinylpyrrolidone prepared by melt extrusion.
    Forster A; Hempenstall J; Rades T
    Pharmazie; 2003 Nov; 58(11):838-9. PubMed ID: 14664344
    [No Abstract]   [Full Text] [Related]  

  • 35. The protection of the skin of fracture patients immobilized in plaster of Paris.
    Boroda C; Mouzas GL
    Surgery; 1974 May; 75(5):638-42. PubMed ID: 4824422
    [No Abstract]   [Full Text] [Related]  

  • 36. Investigation of some materials as dry binders for direct compression in tablet manufacture. Part 4: Effect of disintegrants.
    Asker AF; Saied KM; Abdel-Khalek MM
    Pharmazie; 1975 Jun; 30(6):377-82. PubMed ID: 1161788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ophthalmic solutions: viscosity builders.
    Hill RM; Terry JE
    Am J Optom Physiol Opt; 1974 Nov; 51(11):847-51. PubMed ID: 4432907
    [No Abstract]   [Full Text] [Related]  

  • 38. [Tablets of 7-(3'-(methylhydroxyethylamino)-2'-hydroxypropyl)-theophylline nicotinate with delayed action. I. Moderation of the release of the active substance by some additives].
    Pawlak E; Chodkowska-Granicka B; Surowiecki J
    Acta Pol Pharm; 1971; 28(1):43-7. PubMed ID: 5577811
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of excipients in freeze-dried products for injection.
    Bashir JA; Avis KE
    Bull Parenter Drug Assoc; 1973; 27(2):68-83. PubMed ID: 4707187
    [No Abstract]   [Full Text] [Related]  

  • 40. [Interactions between macromolecular adjuvants and drugs. 10. Influence of polyvinylpyrrolidone on the stability of oxytetracycline].
    Keipert S; Korner I; Voigt R
    Pharmazie; 1977 Jun; 32(6):357-8. PubMed ID: 896944
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.